Correction: Bajbouj et al. Synergistic Anti-Angiogenic Effect of Combined VEGFR Kinase Inhibitors, Lenvatinib, and Regorafenib: A Therapeutic Potential for Breast Cancer. Int. J. Mol. Sci. 2022, 23, 4408
Authors
Rebal S. Abou Assaleh (ORCID: https://orcid.org/0000-0002-1751-2577)
Zeinab Ibrahim (ORCID: https://orcid.org/0000-0002-0320-4127)
Hanadi M. Janajrah
Mohammed A. Alshura
Amenah W. Al Ani
Mohamad B Alebaji (ORCID: https://orcid.org/0000-0002-8114-0157)
Adel B. Elmoselhi (ORCID: https://orcid.org/0000-0003-2152-6629)
Correction: Bajbouj et al. Synergistic Anti-Angiogenic Effect of Combined VEGFR Kinase Inhibitors, Lenvatinib, and Regorafenib: A Therapeutic Potential for Breast Cancer. Int. J. Mol. Sci. 2022, 23, 4408
Rebal S. Abou Assaleh, Zeinab Ibrahim, Hanadi M. Janajrah, Mohammed A. Alshura et al.
Journal
International Journal of Molecular Sciences
Topics
Angiogenesis and VEGF in Cancer
article
Correction: Bajbouj et al. Synergistic Anti-Angiogenic Effect of Combined VEGFR Kinase Inhibitors, Lenvatinib, and Regorafenib: A Therapeutic Potential for Breast Cancer. Int. J. Mol. Sci. 2022, 23, 4408
Rebal S. Abou Assaleh, Zeinab Ibrahim, Hanadi M. Janajrah, Mohammed A. Alshura, Amenah W. Al Ani, Mohamad B Alebaji, Adel B. Elmoselhi, Rizwan Qaisar, Abdelrahman I. Omara, Maha Saber-Ayad, Mariah Malak Bilalaga, Khuloud Bajbouj
article en
Abstract
No abstract available for this paper.
Publication Tag
International Journal of Molecular SciencesVol. 27(2)